Question 1

Which is bigger, LLY or REGN?

Accepted Answer

Eli Lilly & Co. is the larger company — market cap $1.05T vs $76.8B for Regeneron Pharmaceuticals Inc.

Question 2

Which is more profitable, LLY or REGN?

Accepted Answer

LLY keeps more of each revenue dollar as profit — net margin 33.5% vs 27.9% for REGN.

Question 3

Which stock is cheaper, LLY or REGN?

Accepted Answer

On earnings, REGN trades at a lower P/E — 17.8 vs 41.6 for LLY. A lower P/E means paying less per dollar of earnings.

Question 4

Which pays a higher dividend, LLY or REGN?

Accepted Answer

LLY yields 0.52% vs 0.49% for REGN.

Question 5

Which is the better stock — LLY or REGN?

Accepted Answer

On reported financials, LLY leads 9 of 11 comparable metrics and REGN leads 2. StockCV rates LLY “Solid” and REGN “Mixed”. This is information, not investment advice — compare the full CVs before drawing conclusions.

Metric	LLY	REGN
Price	$1 177.20	$745.55
Market cap	$1.05T	$76.8B
Revenue (TTM)	$79.7B	$15.5B
Revenue growth	+31.7%	+5.6%
Net margin	33.5%	27.9%
Free cash flow	$18.2B	$3.76B
Net cash (debt)	($35.2B)	$6.62B
1-year price return	+37.6%	+30.8%
P/E	41.6	17.8
P/E vs own history (cheap-side %)	88%	46%
Dividend yield	0.52%	0.49%
Return on equity	93%	14%
Altman Z-score	7.10	—
CV checks passed	11 of 11	10 of 11
Employees	50,000	15,410

Eli Lilly & Co. vs Regeneron Pharmaceuticals Inc